ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in securities by Directors, Prescribed Officers and the Company Secretary of the Company

Dealing in securities by Directors, Prescribed Officers and the Company Secretary of the Company

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94

DEALING IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY OF THE
COMPANY

In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of
the following information:

DIRECTORS OF THE COMPANY

Director                       :   Stephen Bradley Saad
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   50 310
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R7 183 302.05
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Director                       :   Sean Matthew Capazorio
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   22 851
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R3 262 684.06
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

PRESCRIBED OFFICERS OF THE COMPANY

Prescribed Officer             :   Michael Guy Attridge
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   41 590
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R5 938 253.47
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Prescribed Officer             :   Reginald Haman
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   17 498
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R2 498 378.44
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Prescribed Officer             :   Reginald Haman
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred retention bonus shares (vesting after three, five
                                   and 7 years in tranches of 24 000, 32 000 and 44 000 shares, respectively)
Number of securities           :   100 000
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R14 278 080.00
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Prescribed Officer             :   Lorraine Angela Hill
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   18 215
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R2 600 752.27
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Prescribed Officer             :   Zizipho Mmango
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   17 498
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R2 498 378.44
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Prescribed Officer             :   Zizipho Mmango
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred retention bonus shares (vesting after three, five
                                   and 7 years in tranches of 24 000, 32 000 and 44 000 shares, respectively)
Number of securities           :   100 000
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R14 278 080.00
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Prescribed Officer             :   Mark Sardi
Date of transaction            :   14 September 2022
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   17 498
Class of securities            :   Ordinary shares
Grant price                    :   R142.7808
Value of Transaction           :   R2 498 378.44
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

COMPANY SECRETARY OF THE COMPANY

Company Secretary             :   Riaan Verster
Date of transaction           :   14 September 2022
Nature of transaction         :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities          :   7 558
Class of securities           :   Ordinary shares
Grant price                   :   R142.7808
Value of Transaction          :   R1 079 137.29
Nature of interest            :   Direct beneficial
Clearance obtained            :   Yes

All acceptances of deferred bonus shares are deemed to be off-market trades.

Durban
15 September 2022

Sponsor
Investec Bank Limited

Date: 15-09-2022 11:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.